 |
|
|
 |
VOLUME 33: NO. 3 MARCH 2006
Editorials
Outcome Issues for Rheumatoid Arthritis: What Do We Have and What Do We Want?
Management of Whiplash-Associated Disorders — Revisiting Quebec
The Role of Inflammatory Cytokines in the Pathogenesis of Systemic Lupus Erythematosus-Related Atherosclerosis: A Novel Target for Treatment?
•
Quantitative Clinical Rheumatology Saving Time and Improving Care with a Multidimensional Health Assessment Questionnaire: 10 Practical Considerations
Articles
Effects of Viral IL-10 Introduced by in vivo Electroporation on Arthrogen-Induced Arthritis in Mice
Simvastatin Inhibits Production of IL-6 and IL-8 and Cell Proliferation Induced by TNF-a in Fibroblast-like Synoviocytes from Patients with RA
Quinacrine But Not Chloroquine Inhibits PMA Induced Upregulation of MMP in Leukocytes: Quinacrine Acts at the Transcriptional Level Through a PLA2-Independent Mechanism
Splitting High-Dose Oral MTX Improves Bioavailability: A Pharmacokinetic Study in Patients with RA
Combination of Cyclosporine and Leflunomide versus Single Therapy in Severe RA
Short-term Outcome After Anti-TNF-a Therapy in RA: Do We Need to Revise Our Assessment Criteria?
Anti-CCP Antibodies as a Predictor of Response to Anti-TNF-a Therapy in Patients with RA
Minimal Clinically Important Difference in Radiological Progression of Joint Damage. A Definition Based on Patient Perspective
Loss of Cortical Bone from the Metacarpal Diaphysis
in Patients with RA: Independent Effects of Systemic Inflammation and Glucocorticoids
Cervical Spine Surgery in Patients with RA:
Longterm Mortality and Its Determinants
Polymorphism of the FcgRIIa IgG Receptor in
Patients with Lupus Nephritis and Glomerulopathy
Prevalence of Neurocognitive Dysfunction and Other Clinical Manifestations in Disabled Patients with SLE
Increased Concentration of Proatherogenic Inflammatory Cytokines in SLE: Relationship to Cardiovascular Risk Factors
Proton MRS Reveals Central Neuroaxonal
Impairment in SSc
Developing Classification Criteria for Peripheral
Joint PsA. Step I. Establishing Whether the Rheumatologist's Opinion on the Diagnosis Can
Be Used as the "Gold Standard"
Prospective Observational Analysis of the Efficacy
and Safety of Low-Dose (3 mg/kg) Infliximab in AS:
4-Year Followup
Medication Errors with the Use of Allopurinol and Colchicine: A Retrospective Study of a National, Anonymous Internet-Accessible Error Reporting System
Pennsaid® Therapy for OA of the Knee: A Systematic Review and Metaanalysis of Randomized Controlled Trials
Measurement of Pain Using the Visual Numeric
Scale
Assessing a Whiplash Management Model:
A Population-Based Non-Randomized
Intervention Study
Utilization and Cost Comparison of Current and Optimal Prescribing of NSAID in Quebec, Canada
Pediatric Rheumatology
Comparison of Clinical and Laboratory Variables in Familial versus Sporadic Systemic Onset JIA
Effect of Inflammatory Activity and Glucocorticoid
Use on Nutritional Variables in Patients with JIA
Treatment of Pediatric Localized Scleroderma
with MTX
Chondrocyte Apoptosis and Expression of Bcl-2, Bax, Fas, and iNOS in Articular Cartilage in Patients with Kashin-Beck Disease
Case Reports
Laser Induced Chrysiasis: Disfiguring Hyperpigmentation Following Q-Switched Laser Therapy in a Woman Previously Treated with Gold
Pulmonary Complications of Infliximab Therapy in Patients with RA
Pantoprazole and pANCA-Associated Vasculitis
Images in Rheumatology
Supernumerary Metatarsal Bone
•
Obituary Morris Ziff, 1913-2005
Morris Ziff — On a personal note
Correspondence
Nonsystemic Vasculitic Neuropathy:
A Clinicopathological Study of 22 Cases
Reply
Letter
Bilateral Ocular Myositis as a Late Complication of Dermatomyositis
Meetings in Rheumatology......... |
